Veracyte (VCYT) Change in Account Payables (2012 - 2026)
Veracyte (VCYT) posted quarterly Change in Account Payables of $1.2 million for Q2 2026, up 129.22% year-over-year from $510854.3 in Q2 2025, and down 54.74% on a QoQ basis from $2.6 million in Q1 2026.
Veracyte (VCYT) Change in Account Payables (2012 - 2026) Analysis & Trends
Veracyte has reported Change in Account Payables for 15 years, with the latest figure at $1.2 million in Q2 2026.
- Change in Account Payables for Q2 2026 came in at $1.2 million, up 129.22% year-over-year; the trailing twelve-month figure through Jun 2026 was -$394000.0 (down 176.65% YoY), and the FY2025 annual result was -$1.0 million, up 75.87% from the prior year.
- Change in Account Payables slipped to $1.2 million in Q2 2026, from $2.6 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $7.1 million in Q1 2025 and troughed at -$4.0 million in Q2 2025.
- A 5-year average of -$87111.1 and a median of -$452500.0 in 2022 frame the typical range for Change in Account Payables.
- The largest YoY upside for Change in Account Payables was 561.14% in 2025 against a maximum downside of 2373.46% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $477000.0 in 2022, then sank by 166.88% to -$319000.0 in 2023, then slumped by 324.76% to -$1.4 million in 2024, then jumped by 63.69% to -$492000.0 in 2025, then surged by 338.01% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $1.2 million in Q2 2026, $2.6 million in Q1 2026, and -$492000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -6.74 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 15.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 21.88 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 10.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 674,000.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Mn |
| Jun 30, 2026 | 1.17 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | -492,000.00 |
| Dec 31, 2025 | -492,000.00 |
| Sep 30, 2025 | -3.66 Mn |
| Sep 30, 2025 | -3.66 Mn |
| Jun 30, 2025 | -4.01 Mn |
| Jun 30, 2025 | -4.01 Mn |
| Mar 31, 2025 | 7.12 Mn |
| Mar 31, 2025 | 7.12 Mn |
| Dec 31, 2024 | -1.36 Mn |
| Dec 31, 2024 | -1.36 Mn |
| Sep 30, 2024 | -1.24 Mn |
| Sep 30, 2024 | -1.24 Mn |
| Jun 30, 2024 | -162,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Mar 31, 2024 | -1.54 Mn |
| Mar 31, 2024 | -1.54 Mn |